Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

RLMDRLMD
Showing 8 of 27 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in RELMADA THERAPEUTICS INC

NORTHERN TRUST CORP holds 786,257 shares of RLMD (RELMADA THERAPEUTICS INC), worth $5.4M as of 2026-Q2. The position was increased (+398.5% shares). RLMD represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$5.4M

Current Shares

786,257

Total Value Change

+$5.2M

Total Shares Change

+711,541

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
786,257
+398.5%
$5.4M0.0%$6.92
44
2026-Q1
Decreased
157,734
-4.7%
$1.1M0.0%$4.67
0
2025-Q4
Increased
165,453
+180.3%
$799,1380.0%$4.53
40
2025-Q3
Decreased
59,023
-0.9%
$118,6360.0%$1.88
0
2025-Q2
Unchanged
59,571
0.0%
$35,7600.0%$0.61
0
2025-Q1
Decreased
59,571
-29.3%
$16,0840.0%$0.30
0
2024-Q4
Increased
84,282
+12.8%
$43,8270.0%$0.46
16
2024-Q3
Decreased
74,716
-5.4%
$242,0800.0%$3.37
0

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used